Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report) gapped up before the market opened on Thursday . The stock had previously closed at $17.60, but opened at $18.66. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.76, with a volume of 7,747 shares.
Wall Street Analyst Weigh In
TLX has been the topic of several analyst reports. UBS Group raised their target price on Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, January 27th. William Blair restated an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday, March 12th.
Telix Pharmaceuticals Limited American Depositary Shares Stock Performance
About Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Featured Articles
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- Which Wall Street Analysts are the Most Accurate?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- The How and Why of Investing in Gold Stocks
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
